doi: 10.1006/gyno.1994.1034.
Abrogation of suppressor cells activity by cis-diamminedichloroplatinum (CDDP) treatment using therapeutic doses in ovarian cancer patients
Affiliations
- PMID: 8314142
- DOI: 10.1006/gyno.1994.1034
Item in Clipboard
Abrogation of suppressor cells activity by cis-diamminedichloroplatinum (CDDP) treatment using therapeutic doses in ovarian cancer patients
Gynecol Oncol.
1994 Feb.
Abstract
We examined the activity of natural killer (NK) cells and suppressor cells and the population of peripheral blood lymphocytes before and after cis-diamminedichloroplatinum (CDDP) treatment using therapeutic doses in 15 ovarian cancer patients. CDDP did not decrease NK cell activity but selectively abrogated suppressor cell activity up to 7 days after treatment (P < 0.05). The CD56+CD16+ cell and CD8+CD11+ T cell populations significantly decreased; however, the CD4+2H4+ T cells, showed a significant increase after treatment (P < 0.05). We conclude that CDDP treatment using therapeutic doses could selectively abrogate suppressor cell activity.
Similar articles
-
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.Gynecol Oncol. 2007 Jul;106(1):75-81. doi: 10.1016/j.ygyno.2007.02.029. Epub 2007 Apr 11. Gynecol Oncol. 2007. PMID: 17433425
-
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.Gynecol Oncol. 2008 Feb;108(2):421-7. doi: 10.1016/j.ygyno.2007.10.018. Epub 2007 Nov 26. Gynecol Oncol. 2008. PMID: 18036640
-
[Effect of CDDP administration on NK activity of human peripheral lymphocytes and its modification by corticosteroid as anti-emetic agent].Gan To Kagaku Ryoho. 1984 Mar;11(3):492-6. Gan To Kagaku Ryoho. 1984. PMID: 6538405 Japanese.
-
Partial review of immunotherapeutic pharmacology in stem cell transplantation.In Vivo. 2000 Jan-Feb;14(1):221-36. In Vivo. 2000. PMID: 10757081 Clinical Trial.
-
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.Clin Cancer Res. 1996 Jan;2(1):161-73. Clin Cancer Res. 1996. PMID: 9816103
Cited by
-
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.PLoS One. 2008;3(10):e3409. doi: 10.1371/journal.pone.0003409. Epub 2008 Oct 15. PLoS One. 2008. PMID: 18923710 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
